<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39389072</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-4457</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>The Lancet. Infectious diseases</Title><ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Revisiting MERS-CoV vaccination in the SARS-CoV-2 era.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1473-3099(24)00453-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(24)00453-5</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Batawi</LastName><ForeName>Sarah A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Pandemic Science Institute, University of Oxford, Oxford, UK; Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21362, Saudi Arabia. Electronic address: sarah.batawi@ndm.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alraddadi</LastName><ForeName>Basem M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia; Department of Medicine, Alfaisal University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lancet Infect Dis</MedlineTA><NlmUniqueID>101130150</NlmUniqueID><ISSNLinking>1473-3099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>SAB is a PhD candidate at the University of Oxford (Oxford, UK) and is involved in the ChAdOx1 MERS clinical trials testing. These trials are supported by Coalition for Epidemic Preparedness Innovations, UK National Institutes for Health Research; and Oxford Biomedical Research Centre. Her PhD is funded by the Department of Medical Microbiology and Parasitology at King Abdulaziz University (Jeddah, Saudia Arabia). BMA declares no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39389072</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(24)00453-5</ArticleId><ArticleId IdType="pii">S1473-3099(24)00453-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle>